Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research focused on Breast cancer and Triple-negative breast cancer, with related work in Immunohistochemistry, Glioma, Circulating tumor cell. Notable publications include 'Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis', 'High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients', and 'Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer'.
Significance of ALDH3A2, a mitochondrial metabolism and glycolysis related gene, in pulmonary arterial hypertension
Programmed cell death: A pivotal player in pulmonary arterial hypertension
Analysis of the clinical effects of the transvertebral anterior approach for contralateral C7 nerve translocation in treating Central upper limb paralysis: a retrospective study
Ginsenoside Rg3 overcomes tamoxifen resistance through inhibiting glycolysis in breast cancer cells
Pyroptotic macrophages promote proliferation and chemotherapy resistance of <scp>peripheral T‐cell lymphoma</scp> via <scp>TLR4</scp> signaling pathway
Preliminary safety and efficacy of TQB2930, a HER2-targeted bispecific antibody in patients with advanced breast cancer: Results from a phase 1b study.
Glucocorticoid receptor regulates the epithelial-mesenchymal transition process through GR/ZEB1/E-cad and is involved in breast cancer endocrine drug resistance—a bioinformatics analysis
An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China
Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer
RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients
The Expression of CD9 and PIK3CD is Associated with Prognosis of Follicular Lymphoma
Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer
Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis
Indications of Clinical and Genetic Predictors for Aromatase Inhibitors Related Musculoskeletal Adverse Events in Chinese Han Women with Breast Cancer
Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population
High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients
Circulating Tumor Cells (CTCs) Detected by Triple-Marker EpCAM, CK19, and hMAM RT-PCR and Their Relation to Clinical Outcome in Metastatic Breast Cancer Patients
Low expression of <scp>RECK</scp> indicates a shorter survival for patients with invasive breast cancer